Related by context. All words. (Click for frequent words.) 82 % CI #.#-#.# [006] 81 % CI #.#-#.# [003] 81 % CI #.#-#.# [008] 78 CI #.#-#.# [001] 77 confidence interval CI 77 CI #.#-#.# [002] 76 P = .# 76 confidence interval #.#-#.# 75 p = .# [002] 74 % Confidence Interval 73 % CI #.#-#.# [002] 72 pT3 72 p = NS 72 CI -#.# 72 neurodevelopmental impairment 71 CI = 71 % CI #.#-#.# [004] 70 CR nPR 70 nondiabetic patients 70 biochemical relapse 70 adjunctive placebo 70 p = #.# [003] 70 lymphocytosis 70 p = .# [001] 70 preoperative PSA 70 â ‰ ¥ 70 ALT elevation 69 sd = 69 lopinavir r arm 69 leucopenia 69 interquartile range 69 FOLFIRI alone 69 univariate analysis 69 advanced adenoma 69 hypophosphatemia 69 MADRS score 69 HBeAg negative patients 69 #.#/# [005] 69 de novo AML 69 CC genotype 69 Median PFS 69 liver histology 68 p ≤ 68 LV dysfunction 68 Flu Cy 68 recurrent VTE 68 FluCAM arm 68 CR CRu 68 lowest tertile 68 REYATAZ r arm 68 Ishak fibrosis score 68 multivariable adjusted 68 Breslow thickness 68 CCyR 68 % CI #.#-#.# [001] 68 mL/min/#.# m 2 68 confidence intervals CIs 68 median PFS 68 nonobese patients 68 receiving ISENTRESS 68 hours postdose 68 progression TTP 68 deep venous thromboses 68 seropositivity 68 PSA nadir 68 malignant neoplasm 67 HbA 1c levels 67 nonsignificant difference 67 DAS# remission 67 preintervention 67 HBeAg negative 67 % CI #.#-#.# [005] 67 histologically confirmed 67 AOR = 67 IPAH 67 posttransplant 67 alanine aminotransferase ALT 67 CIN3 67 arterial thromboembolic events 67 microbiologically evaluable 67 elevated ALT 67 EDSS score 67 anemia hemoglobin 67 Partial Response 67 postintervention 67 leukopenia 67 mcg albinterferon alfa 2b 67 methotrexate monotherapy 67 p = ns 67 SGPT 67 colorectal adenoma 67 perioperative complications 67 euthyroid 67 hepatorenal syndrome 67 TT genotype 67 pCR 67 affective psychosis 67 aged ≥ 67 pg ml 67 invasive carcinomas 67 amoxicillin clavulanate 67 μmol L 66 hip BMD 66 KRAS mutations occur 66 MACCE 66 Partial Responses 66 parous women 66 postoperative complication 66 nonobese 66 histological subtype 66 EDSS scores 66 neutrophil counts 66 pulmonary dysfunction 66 acute cholecystitis 66 P ≤ 66 NNT = 66 MMSE score 66 severe exacerbations 66 recurrent UTI 66 mcg BID 66 extracapsular extension 66 severe neutropenia 66 idiopathic PAH 66 fatigue asthenia 66 4mg/kg 66 mIU L 66 x ULN 66 definite stent thrombosis 66 achieved ACR# 66 biochemical recurrence 66 -#.# ± [002] 66 ertapenem 66 postop 66 oxycodone CR 66 binary restenosis 66 alanine aminotransferase 66 nonfatal MI 66 underwent surgical resection 66 biopsy Gleason 66 NMIBC 65 β = 65 lymphopenia 65 QTcF 65 pmol L 65 thrombocytopenic 65 SUVmax 65 locoregional recurrence 65 HBeAg positive patients 65 PREZISTA r arm 65 mild renal insufficiency 65 lumbar spine BMD 65 HBeAg seroconversion 65 sensory neuropathy 65 HF hospitalization 65 noncardiac 65 MMSE scores 65 generalized edema 65 p = 65 ipsilateral stroke 65 ‰ ¥ 65 pT2 65 BMI z 65 advanced adenomas 65 achieved CCyR 65 mucosal inflammation 65 chlorambucil 65 Kaplan Meier analysis 65 receiving VICTRELIS 65 multivariable analyzes 65 comparator arm 65 tipranavir r 65 relapsed MM 65 GG genotype 65 aOR 65 highest tertile 65 mcg QD 65 interquartile range IQR 65 polyp recurrence 65 advanced neoplasia 65 PSADT 65 chorioamnionitis 65 invasive lobular 65 Operative mortality 65 Stent thrombosis 65 perioperatively 65 leukocyte count 65 univariate analyzes 65 pmol liter 65 ECOG PS 65 ≥ 65 5-FU/LV 65 transaminase elevations 65 ug dose 65 overt nephropathy 65 diabetes mellitus DM 65 adjunctive ABILIFY 65 nonsevere 65 logistic regression analysis 65 #.#/#.# mmHg [001] 65 FOLFOX4 65 rebleeding 65 complete cytogenetic response 65 DAS# [002] 65 Index CDAI 65 #.#ng/ml 65 HBeAg 64 antiretroviral naïve 64 pulmonary resection 64 pretest probability 64 stage IIIb IV 64 #Gy 64 elevated LDH 64 mg/m2 dose 64 underwent resection 64 bronchopulmonary dysplasia 64 operable breast cancer 64 homozygotes 64 histologic subtype 64 p = #.# [002] 64 prevalences 64 systolic dysfunction 64 IQR = 64 CVD mortality 64 KRAS mutant tumors 64 #mg BID [001] 64 timepoints 64 mmHg diastolic 64 SLNB 64 COPD exacerbation 64 #OHD 64 DAS# CRP 64 metastatic malignant 64 pg mL 64 nmol l 64 intraventricular hemorrhage 64 BMI ≥ 64 refractory ischemia 64 mg BID dose 64 log# copies mL 64 del 5q 64 posttreatment 64 cranial irradiation 64 antibody titer 64 Hazard Ratio 64 hepatitis C genotype 64 CrCl 64 salmeterol fluticasone 64 squamous histology 64 mU liter 64 reinfarction 64 cGy 64 lymph node metastasis 64 ALT elevations 64 octreotide LAR 64 reflux esophagitis 64 pericardial effusion 64 abacavir lamivudine 64 μg liter 64 EGFR mutation positive 64 obstructive coronary artery 64 obstructive CAD 64 morphometric vertebral fractures 64 recurrent venous thromboembolism 64 renal scarring 64 elevated transaminases 64 Infusion Reactions Severe 64 bronchoalveolar lavage 64 clodronate 64 mIU ml 64 VcMP 64 locoregional 64 external genital lesions 64 tolterodine ER 64 SGRQ 64 incidence ≥ 64 antithymocyte globulin 64 microbiological eradication 64 asthma exacerbation 64 Viread Emtriva Sustiva 64 URTI 64 TAXUS p value 64 hematologic toxicity 64 MCyR 64 distant metastasis 64 mild renal impairment 64 CI #.#-#.# p = 64 -#.# log# 64 baseline HbA1c 64 graft occlusion 64 placebo dexamethasone 64 median survivals 64 tertile 64 nmol L. 64 acute myeloid 64 nonexposed 64 #mmHg [001] 64 nadroparin 64 microg 63 ischemia driven 63 baseline LDH 63 multivariate Cox 63 odds ratios ORs 63 RYGB 63 undergoing liver transplantation 63 serum urate levels 63 Univariate analysis 63 mg kg dose 63 parasitaemia 63 MetS 63 multivariate adjustment 63 lamivudine monotherapy 63 intact parathyroid hormone 63 extrapulmonary 63 HbA1C levels 63 ALT flares 63 neurologic progression 63 Hb A1C 63 cerebrovascular accidents 63 mmol l 63 femoral neck BMD 63 atheroma volume 63 TEAEs 63 n = 63 invasive ductal 63 NIHSS 63 neoplasias 63 Febrile neutropenia 63 pyelonephritis 63 Scale EDSS 63 angiographically 63 HOMA IR 63 total thyroidectomy 63 comorbid anxiety 63 pheochromocytoma 63 febrile neutropenia 63 neutropaenia 63 = #.#-#.# 63 autonomic dysfunction 63 infliximab monotherapy 63 aspartate aminotransferase 63 mcg linaclotide 63 NNRTI resistance 63 euthymic patients 63 umol L 63 endometrial carcinoma 63 cirrhotic 63 venlafaxine XR 63 pulmonary exacerbation 63 p = #.# [004] 63 lactate dehydrogenase 63 symptomatic intracranial 63 neutropenic sepsis 63 cough dyspnea 63 tipranavir ritonavir 63 grade cervical intraepithelial 63 postoperative morbidity 63 nonmetastatic 63 creatinine ratio 63 Postoperatively 63 HAM D# scores 63 unresectable HCC 63 LV ejection fraction 63 deletion 5q 63 Brief Psychiatric 63 glycated hemoglobin levels 63 smoldering myeloma 63 inhospital 63 symptomatic VTE 63 nodal metastases 63 PASI scores 63 HIV uninfected 63 hormone receptor negative 63 seminal vesicle invasion 63 nmol L 63 anastomotic leak 63 atrophic gastritis 63 non splenectomized 63 histologically proven 63 experienced virologic failure 63 PaO 2 63 proximal DVT 63 pretransplant 63 Folfox 63 tirofiban 63 corticosteroid dose 63 receiving golimumab 63 tuberculin skin testing 63 multivariable analysis 63 SCr 63 Multivariate analysis 63 TURBT 63 Postoperative complications 63 bronchioloalveolar carcinoma 63 mutated KRAS 63 upper airway obstruction 63 log# reduction 63 seroconverted 63 imipenem 63 CIMZIA TM certolizumab pegol 63 SSc 63 nmol liter 63 hemorrhagic cystitis 63 mL/min/#.# m2 62 coronary stenosis 62 pancreatic fistula 62 8mg/kg 62 detrusor overactivity 62 plus OBT 62 g dl 62 Hazard Ratio HR 62 Serum creatinine 62 nicardipine 62 recurrent myocardial infarction 62 AST ALT 62 placebo PBO 62 IU ml 62 rheumatoid factor 62 Y BOCS 62 node metastases 62 multivariate analyzes 62 chemoradiation therapy 62 Thal Dex 62 Adjuvant chemotherapy 62 perianal 62 adnexal mass 62 endometrial thickness 62 androgen suppression 62 Crohn Disease Activity 62 Pneumocystis carinii pneumonia 62 unfavorable cytogenetics 62 conjunctival hyperemia 62 ADPKD 62 CDAI 62 trimethoprim sulfamethoxazole 62 virologic failure 62 mean baseline A1C 62 moderate renal impairment 62 Complication rates 62 normoxic 62 serum IGF 62 NSTEMI 62 aminotransferase elevations greater 62 β blockers 62 RECIST criteria 62 placebo p = 62 pulmonary embolus 62 μg L 62 thromboembolism 62 KRAS wild 62 abdominal irradiation 62 hematopoietic cancers 62 ASCUS 62 axillary node 62 BARACLUDE ® 62 intima media thickness 62 preterm neonates 62 VLBW 62 Zometa hazard 62 CIN2 + 62 mg p = 62 undetectable HBV DNA 62 HCV genotype 62 BRCA1 mutation carriers 62 fluticasone salmeterol 62 postoperative AF 62 nmol 62 aortic atherosclerosis 62 MBq 62 AUC0 62 inhospital mortality 62 perioperative mortality 62 leukemia AML 62 extrapyramidal symptoms 62 FLT3 ITD 62 TMP SMX 62 cisplatin vinorelbine 62 PEG IFN 62 clinically evaluable patients 62 thyroid carcinoma 62 splenectomized 62 T1c 62 #mg/day [001] 62 HLA DR4 62 IQR 62 del 5q MDS 62 NYHA functional class 62 rimonabant #mg 62 renal insufficiency 62 genotypic resistance 62 diastolic hypertension 62 interferon ribavirin 62 response CCyR 62 nodal metastasis 62 Kaplan Meier 62 locoregional disease 62 mEq L 62 empyema 62 adefovir treated 62 receiving Vectibix monotherapy 62 GH deficiency 62 IIIa inhibitors 62 micafungin 62 prospectively defined 62 hepatocellular carcinomas 62 Expanded Disability Status 62 Charlson comorbidity index 62 mechanically ventilated patients 62 periprocedural 62 UGT#A# * 62 recurrent glioblastoma multiforme 62 Subgroup analysis 62 nonischemic cardiomyopathy 62 Papillary 62 mRS 62 leukocytosis 62 nodular partial response 62 intravesical therapy 62 neurologic complications 62 NIH CPSI 62 CIN2 62 J. Clin 62 S aureus 62 certolizumab 62 kg m² 62 nulliparous women 62 receiving APTIVUS r 62 ß = 62 graft dysfunction 62 plus methotrexate 62 TPV r 62 uM 62 patients evaluable 62 dysuria 62 POAG 62 ovarian carcinoma 62 chronic HCV genotype 62 genotype 1b 62 elevated IOP 62 adenoidectomy 62 IFN alfa 62 XIENCE V PROMUS Stent 62 seronegative 62 Hazard Ratio = 62 femoral shaft fracture 62 plasma uric acid 62 ug kg 62 recurrent genital herpes 62 cisplatin chemotherapy 62 recurrent wheezing 62 nonsignificant 62 lymphovascular invasion 62 seropositive patients 62 adenoma recurrence 62 squamous cell carcinoma SCC 62 pooled comparator 62 visceral metastases 62 radical nephrectomy 62 TMC# r 62 completely resected 62 sirolimus stent 62 neutropenia febrile neutropenia 62 VT VF 62 lymphadenectomy 61 tPSA 61 hemoptysis 61 troponin T 61 postprocedure 61 colorectal carcinoma 61 haematologic 61 annualized relapse 61 fasting triglyceride levels 61 recurrent atrial fibrillation 61 baseline FEV 61 CP CPPS 61 serum creatinine levels 61 cases/# 61 peritoneal cancer 61 postoperative pulmonary 61 mediastinitis 61 glomerular filtration 61 nondiabetic 61 normal ULN 61 normothermic 61 bronchial hyperresponsiveness 61 metastatic malignant melanoma 61 headache abdominal pain 61 papillary renal cell carcinoma 61 hydronephrosis 61 #.#/#.# mm Hg [003] 61 vesicoureteral reflux 61 QRS duration 61 intraperitoneally 61 metastatic GIST 61 lopinavir r 61 Kaplan Meier estimates 61 FDG uptake 61 HER2 expression 61 salmeterol fluticasone propionate 61 adenotonsillectomy 61 hypokalemia 61 neutropenia dehydration dyspnea 61 μg ml 61 proband 61 postoperative chemotherapy 61 preoperative chemotherapy 61 serum aminotransferase levels 61 CRu 61 cholangiocarcinoma 61 mmHg systolic 61 pamidronate 61 CLL SLL 61 lymphocyte count 61 pancreatic adenocarcinoma 61 logistic regression model 61 CDAI score 61 mitoxantrone plus 61 systolic blood pressures 61 intestinal metaplasia 61 laboratory abnormalities 61 Secondary endpoints included 61 psychiatric comorbidities 61 papillary thyroid carcinoma 61 preeclamptic 61 carotid stenosis 61 BCG vaccinated 61 colorectal neoplasms 61 virological failure 61 underwent CABG 61 gastric adenocarcinoma 61 atazanavir ritonavir 61 enteroviral 61 virologic response 61 symptomatic intracranial hemorrhage 61 thrombocytosis 61 neurologic outcomes 61 autoantibody positive 61 neurologic impairment 61 μg kg 61 tapentadol ER 61 tertiles 61 radiotherapy RT 61 coinfected patients 61 coinfected 61 highest quintile 61 Preoperatively 61 brachial plexus palsy 61 undergoing radical cystectomy 61 methacholine challenge 61 clinicopathological features 61 juvenile idiopathic arthritis JIA 61 Acute Myeloid Leukaemia AML 61 CTEPH 61 progesterone receptor negative 61 receiving XGEVA 61 #q# deletion syndrome 61 tumor histology 61 hsCRP levels 61 #.#-#.# p = 61 bacteremic 61 ALT normalization 61 isoprostane 61 invasive aspergillosis 61 doxorubicin docetaxel 61 coagulopathy 61 subtrochanteric 61 nontraumatic 61 Prognostic significance 61 candidemia 61 distant metastases 61 Response Evaluation Criteria 61 budesonide pMDI 61 EpCAM expression 61 Median survival 61 chronic rhinosinusitis 61 response pCR 61 PCa 61 collagenous colitis 61 recurrent acute pancreatitis 61 postoperative delirium 61 HGPIN 61 Doxil ® 61 angioneurotic edema 61 fetal malformations 61 hepatic enzymes 61 postoperative infections 61 ischemic lesions 61 ductal lobular 61 EBRT 61 Tumor shrinkage 61 depressive symptomatology 61 gastrointestinal perforation 61 IBDQ 61 astrocytomas 61 hypoxemia 61 attain statistical significance 61 Visual Analogue Scale VAS 61 elevated triglyceride levels 61 nonvertebral fractures 61 piperacillin tazobactam 61 prostate cancer CaP 61 VaD 61 liver decompensation 61 PegIFN RBV 61 neoplasm 61 Peg IFN 61 TAXUS Express Stent 61 bacteriuria 61 μg mL 61 post transplant lymphoproliferative 61 preoperatively 61 anagrelide 61 Plasma concentrations 61 rFSH 61 C difficile infection 61 rhinoconjunctivitis 61 prior chemotherapy regimens 61 atrioventricular block 61 neutropenic fever 61 dalteparin 61 eplerenone 61 rs# [004] 61 RBC transfusion 61 liver metastasis 61 LVEF 61 femoral neck fracture 61 nonfatal myocardial infarction 61 BRCA mutation carriers 61 gastrectomy 61 urolithiasis 61 prolactin elevation 61 relapsed refractory AML 61 left ventricular systolic 61 clinically evaluable 61 arteriolar 61 pulmonary exacerbations 61 pericardial effusions 61 cerebrovascular accident 61 mmol liter 61 surgically resectable 61 FEV ^ sub 61 cutaneous melanoma 61 reintervention 61 plus dexamethasone 61 oxycodone IR 61 oral allopurinol 61 recurrent DVT 61 thromboembolic events 61 NIHSS score 61 coronary calcification 61 salmeterol HFA MDI 61 ß blockers 61 FDA defined valvulopathy 61 lymph node involvement 61 acneform rash 61 pleural effusion 61 cytogenetic abnormalities 61 autoimmune thyroid 61 precancerous cervical 61 neurologic sequelae 61 mL kg 61 thymoma 61 cervical intraepithelial neoplasia 61 IOP lowering 61 HIV coinfected 61 ANCA associated 61 heterozygotes 60 -#.# mg dL [002] 60 peginterferon alfa 2a 60 nonmelanoma skin cancers 60 prostate carcinoma 60 ejection fractions 60 HER2 positive cancers 60 oligohydramnios 60 dacarbazine DTIC 60 latent celiac disease 60 bacteraemia 60 steroid dexamethasone 60 adriamycin 60 atopic asthma 60 retransplantation 60 intraabdominal 60 achieved statistical significance 60 bilateral oophorectomy 60 moderately emetogenic 60 Insulin sensitivity 60 partial remissions 60 regression coefficient 60 sonographically 60 Retreatment 60 thromboembolic 60 null responder 60 adverse cytogenetics 60 invasive fungal infection 60 arterial occlusion 60 rizatriptan 60 crossclamp 60 gastroduodenal 60 cytopenias 60 cardiovascular hospitalizations 60 ALND 60 primary aldosteronism 60 nondepressed 60 myelodysplastic myeloproliferative diseases 60 serum sodium levels 60 psychiatric morbidity 60 FluCAM 60 PANSS scores 60 ATV RTV 60 serum cortisol 60 mRCC 60 hepatic metastases 60 clinically meaningful improvement 60 LPS induced 60 inotropic 60 aspartate aminotransferase AST 60 bisoprolol 60 revascularizations 60 C. trachomatis 60 prospectively evaluated 60 familial aggregation 60 mcg mL 60 PREZISTA ritonavir 60 idiopathic pulmonary arterial hypertension 60 XIENCE V demonstrated 60 mg Proellex 60 ALT AST 60 FOLFOX 60 psychiatric comorbidity 60 Baseline characteristics 60 neovascular glaucoma 60 intravitreal injections 60 neurological manifestations 60 breast carcinoma 60 mg ustekinumab 60 nonobstructive 60 statistically significant predictor 60 achieved sustained virological 60 subscore 60 sinus node dysfunction 60 underwent radical prostatectomy 60 urethral stricture 60 atopic disorders 60 pegIFN 60 systemic corticosteroid 60 PPCM 60 serum estradiol 60 ELBW infants 60 patients undergoing CABG 60 myalgia arthralgia 60 immunocompetent patients 60 segment binary restenosis 60 dose dexamethasone 60 lacunar 60 VLBW infants 60 conventional DMARDs 60 echocardiographic parameters 60 Free Survival PFS 60 recurrent metastatic 60 spontaneous bacterial peritonitis 60 extensive metabolizers 60 HAQ DI 60 lower extremity amputation 60 adrenalectomy 60 evaluable 60 hyper IgE syndrome 60 IPSS 60 distal colon cancer 60 QIDS SR 60 CHD CVD 60 virologic breakthrough 60 chronic GVHD 60 CMV infection 60 lamivudine refractory patients 60 Legg Calvé Perthes disease 60 μg d 60 atypical hyperplasia 60 serum concentrations 60 Suicidal ideation 60 variceal bleeding 60 cytoreduction 60 Pred Forte 60 normotensive 60 gemcitabine carboplatin 60 seroprotection 60 oral Hycamtin 60 vaginal hysterectomy 60 primary patency 60 metastatic lung cancer 60 statistically significant p = 60 paroxysmal AF 60 ml kg 60 mCRPC 60 MIC# [001] 60 thrombophlebitis 60 ug ml 60 mucinous 60 solifenacin 60 plus aztreonam 60 HIV HCV coinfected 60 STN stimulation 60 serum ALT 60 HRCT 60 idiopathic thrombocytopenic purpura 60 infective endocarditis 60 interleukin IL -6 60 PCWP 60 Arch Intern Med 60 receiving highly emetogenic 60 episodic migraine 60 Engerix B 60 nadolol 60 gross hematuria 60 basal cell carcinoma BCC 60 gm dl 60 metastatic gastric 60 CYP#D# inhibitor 60 initiating antiretroviral therapy 60 subclinical hypothyroidism 60 nonalcoholic steatohepatitis NASH 60 HbA1c levels 60 FOLFIRI 60 pulmonary capillary wedge 60 affective psychoses 60 gestational diabetes mellitus GDM 60 hypertension diabetes mellitus 60 osteopenic 60 T2 lesions 60 wound dehiscence 60 somatostatin analog 60 plus medroxyprogesterone acetate 60 Hurthle cell 60 postdischarge 60 isolated systolic hypertension 60 LNG IUS 60 Idiopathic Pulmonary Fibrosis 60 #mg QD [001] 60 LPV r 60 macroalbuminuria 60 refractory NSCLC 60 androgen ablation 60 β blocker 60 gestational hypertension 60 neutropenia thrombocytopenia 60 proctitis 60 cryptogenic 60 ug mL 60 VUR 60 adenomatous polyps 60 antiretroviral naive 60 methotrexate therapy 60 nondiabetics 60 foveal thickness 60 hemodynamically significant 60 tenecteplase 60 VELCADE melphalan 60 LRTI 60 mg/m2/day 60 metastatic carcinoid tumors 60 #mg/m# [001] 60 -#.# log# copies mL 60 elevated serum creatinine 60 K ras mutations 60 S. aureus isolates 60 intrapartum 60 Stomatitis 60 coinfection 60 T2DM 60 radical prostatectomy RP 60 transferrin saturation 60 nonobstructive CAD 60 localized renal 60 venous thrombosis 60 orchitis 60 lavage fluid 60 S. aureus infection 60 acromegalic patients 60 periventricular leukomalacia 60 hypercalciuria 60 decompensated cirrhosis 60 mU L 60 schizophreniform disorder 60 malignant neoplasms 60 LVNC 60 heFH 60 lowest quintile 60 oxygen desaturation 60 mg QD 60 Scale EDSS score 60 albumin excretion rate 60 vasopressor 60 CIN3 + 60 plasma cortisol 60 HBeAg positive 60 daunorubicin 60 dapagliflozin plus 60 concomitant antibiotics 60 stage IIIB 60 serum potassium 60 cerebrovascular events